Patient presents with complaints consistent with metastatic colorectal cancer.  Symptoms include [Specify presenting symptoms, e.g., abdominal pain, rectal bleeding, change in bowel habits, fatigue, weight loss, anemia].  Physical examination revealed [Specify findings, e.g., abdominal tenderness, palpable mass, hepatomegaly, lymphadenopathy].  Patient history includes [Specify relevant medical history, e.g., family history of colon cancer, inflammatory bowel disease, previous colon polyps].  Diagnostic workup included colonoscopy with biopsy, which revealed adenocarcinoma of the colon.  CT imaging of the abdomen, pelvis, and chest demonstrated metastatic disease to the [Specify location of metastasis, e.g., liver, lungs, peritoneum].  Carcinoembryonic antigen (CEA) levels are [Specify CEA level].  Based on these findings, the diagnosis of metastatic colorectal cancer (stage IV) is confirmed.  Treatment plan discussion included options such as systemic chemotherapy with [Specify regimen, e.g., FOLFOX, FOLFIRI, CapeOx], targeted therapy [Specify targeted therapy, e.g., Bevacizumab, Cetuximab, Panitumumab] if indicated by molecular testing (KRAS, NRAS, BRAF), and consideration for surgical resection of primary tumor andor metastatic lesions if deemed appropriate.  Patient was counseled on the prognosis, potential treatment side effects, and the importance of regular follow-up.  Referral to oncology, surgery, and palliative care as indicated.  Diagnosis codes: C78.5 (Secondary malignant neoplasm of colon), C80.0 (Malignant neoplasm of colon, unspecified).  Procedure codes will be documented based on procedures performed.